DARATUMUMAB, A CD38 MONOCLONAL ANTIBODY STUDY IN ADVANCED MULTIPLE MYELOMA - AN OPEN-LABEL, DOSE ESCALATION FOLLOWED BY OPEN-LABEL EXTENSION IN A SINGLE-ARM PHASE I/II STUDY

被引：0
|
作者：
Lokhorst, H. [1 ]
Plesner, T. [2 ]
Gimsing, P. [3 ]
Nahi, H. [4 ]
Lisby, S. [5 ]
Richardson, P. [6 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] Vejie Hosp, Vejie, Denmark
[3] Copenhagen Univ Hosp, Copenhagen, Denmark
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Genmab A S, Copenhagen, Denmark
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S576
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [21] An Open-label Dose-escalation Study of BIBF 1120 in Patients with Relapsed or Refractory Multiple Myeloma
    Kropff, Martin
    Kienast, Joachim
    Bisping, Guido
    Berdel, Wolfgang E.
    Gaschler-Markefski, Birgit
    Stopfer, Peter
    Stefanic, Martin
    Munzert, Gerd
    ANTICANCER RESEARCH, 2009, 29 (10) : 4233 - 4238
  • [22] HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
    Shi-Ming Lin
    Sheng-Nan Lu
    Ping-Tsung Chen
    Long-Bin Jeng
    Shinn-Cherng Chen
    Chi-Tan Hu
    Sien-Sing Yang
    Marie-Aude Le Berre
    Xuan Liu
    David Y. Mitchell
    Klaas Prins
    Joachim Grevel
    Carol A. E. Peña
    Gerold Meinhardt
    Hepatology International, 2017, 11 : 199 - 208
  • [23] Cyclosporine in treatment of progressive vitiligo: An open-label, single-arm interventional study
    Taneja, Atul
    Kumari, Asha
    Vyas, Kapil
    Khare, Ashok Kumar
    Gupta, Lalit Kumar
    Mittal, Asit Kumar
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2019, 85 (05): : 528 - +
  • [24] A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis
    Fox, E. J.
    Sullivan, H. C.
    Gazda, S. K.
    Mayer, L.
    O'Donnell, L.
    Melia, K.
    Lake, S. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (02) : 307 - 311
  • [25] An open-label, dose-escalation phase lb study of subcutaneous daratumumab with recombinant human hyaluronidase in patients with relapsed or refractory multiple myeloma (PAVO).
    Nahi, Hareth
    Hellemans, Peter
    Masterson, Tara J.
    Clemens, Pamela L.
    Ahmadi, Tahamtan
    San Miguel, Jesus
    Mateos, Maria-Victoria
    Usmani, Saad Zafar
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma part 2 of the open-label, multicenter, dose-escalation phase Ib study (PAVO)
    San-Miguel, Jesus
    Usmani, Saad Z.
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    Liu, Kevin
    Hellemans, Peter
    Masterson, Tara
    Clemens, Pamela L.
    Luo, Man
    Farnsworth, Andrew
    Nahi, Hareth
    Chari, Ajai
    HAEMATOLOGICA, 2021, 106 (06) : 1725 - 1732
  • [27] Tucidinostat plus toripalimab in patients with unresectable or metastatic melanoma: An open-label, single-arm phase II study
    Mao, Lili
    Dai, Jie
    Bai, Xue
    Kong, Yan
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Lian, Bin
    Tang, Bixia
    Yan, Xieqiao
    Wang, Xuan
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Juan
    Li, Caili
    Duan, Rong
    Xu, Huayan
    Guo, Jun
    Si, Lu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Open-Label, Single-Arm, Phase II Study of Everolimus in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
    Johnston, Patrick B.
    Pinter-Brown, Lauren
    Rogerio, Jaqueline
    Warsi, Ghulam
    Graham, Anne
    Ramchandren, Radhakrishnan
    BLOOD, 2011, 118 (21) : 1169 - 1169
  • [29] Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme
    Del Rowe, J
    Scott, C
    Werner-Wasik, M
    Bahary, JP
    Curran, WJ
    Urtasun, RC
    Fisher, B
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1254 - 1259
  • [30] BendamustinetreatmentofChinesepatientswithrelapsedindolentnon-Hodgkinlymphoma:amulticenter,open-label,single-arm,phase3study
    Shi Yuan-Kai
    Hong Xiao-Nan
    Yang Jian-Liang
    Xu Wei
    Huang Hui-Qiang
    Xiao Xiu-Bin
    Zhu Jun
    Zhou Dao-Bin
    Han Xiao-Hong
    Wu Jian-Qiu
    Zhang Ming-Zhi
    Jin Jie
    Ke Xiao-Yan
    Li Wei
    Wu De-Pei
    Yang Shen-Miao
    Du Xin
    Jia Yong-Qian
    Liu Ai-Chun
    Liu Dai-Hong
    Shen Zhi-Xiang
    Zhang Lian-Sheng
    James Leonard
    Hellriegel Edward
    中华医学杂志英文版, 2021, 134 (11) : 1299 - 1309
12345